Advances in oral immunomodulating therapies in relapsing multiple sclerosis
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference46 articles.
1. Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions;Mehling;Curr Neurol Neurosci Rep,2011
2. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis;Diebold;J Autoimmun,2018
3. Teriflunomide and its mechanism of action in multiple sclerosis;Bar-Or;Drugs,2014
4. Potential mechanisms of action related to the efficacy and safety of cladribine;Baker;Mult Scler Relat Disord,2019
5. Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database;Boster;Neurol Ther,2017
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate;International Journal of Biological Macromolecules;2024-10
2. An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators;Medicinal Research Reviews;2024-04-25
3. Treatment discontinuation in older people with multiple sclerosis;Current Opinion in Neurology;2024-04-03
4. Type I Interferon Signalling and Ischemic Stroke: Mechanisms and Therapeutic Potentials;Translational Stroke Research;2024-03-11
5. PHPB ameliorates memory deficits and reduces oxidative injury in Alzheimer’s disease mouse model by activating Nrf2 signaling pathway;Acta Pharmacologica Sinica;2024-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3